# Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.

> **NCT06334874** · PHASE4 · UNKNOWN · sponsor: **Future University in Egypt** · enrollment: 80 (estimated)

## Conditions studied

- Community-acquired Pneumonia

## Interventions

- **DRUG:** Astaxanthin Oral Capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06334874
- **Lead sponsor:** Future University in Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06334874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06334874, "Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06334874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*